Your browser doesn't support javascript.
loading
A CAD System for Alzheimer's Disease Classification Using Neuroimaging MRI 2D Slices.
Sethi, Monika; Rani, Shalli; Singh, Aman; Mazón, Juan Luis Vidal.
Afiliación
  • Sethi M; Chitkara University Institute of Engineering & Technology, Chitkara University, Punjab, India.
  • Rani S; Chitkara University Institute of Engineering & Technology, Chitkara University, Punjab, India.
  • Singh A; Faculty of Engineering, Universidade Internacional do Cuanza, Estrada Nacional 250, Bairro Kaluapanda, Cuito-Bié, Angola.
  • Mazón JLV; Higher Polytechnic School, Universidad Europea del Atlántico, C/Isabel Torres 21, 39011 Santander, Spain.
Comput Math Methods Med ; 2022: 8680737, 2022.
Article en En | MEDLINE | ID: mdl-35983528
ABSTRACT
Developments in medical care have inspired wide interest in the current decade, especially to their services to individuals living prolonged and healthier lives. Alzheimer's disease (AD) is the most chronic neurodegeneration and dementia-causing disorder. Economic expense of treating AD patients is expected to grow. The requirement of developing a computer-aided technique for early AD categorization becomes even more essential. Deep learning (DL) models offer numerous benefits against machine learning tools. Several latest experiments that exploited brain magnetic resonance imaging (MRI) scans and convolutional neural networks (CNN) for AD classification showed promising conclusions. CNN's receptive field aids in the extraction of main recognizable features from these MRI scans. In order to increase classification accuracy, a new adaptive model based on CNN and support vector machines (SVM) is presented in the research, combining both the CNN's capabilities in feature extraction and SVM in classification. The objective of this research is to build a hybrid CNN-SVM model for classifying AD using the MRI ADNI dataset. Experimental results reveal that the hybrid CNN-SVM model outperforms the CNN model alone, with relative improvements of 3.4%, 1.09%, 0.85%, and 2.82% on the testing dataset for AD vs. cognitive normal (CN), CN vs. mild cognitive impairment (MCI), AD vs. MCI, and CN vs. MCI vs. AD, respectively. Finally, the proposed approach has been further experimented on OASIS dataset leading to accuracy of 86.2%.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva Límite: Humans Idioma: En Revista: Comput Math Methods Med Asunto de la revista: INFORMATICA MEDICA Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva Límite: Humans Idioma: En Revista: Comput Math Methods Med Asunto de la revista: INFORMATICA MEDICA Año: 2022 Tipo del documento: Article País de afiliación: India